The variant affects gene GRIA2 (glutamate ionotropic receptor AMPA type subunit 2), which is on Chromosome 4. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary.
Pathogenic; Neurodevelopmental disorder with language impairment and behavioral abnormalities